Indications for permanent pacing and pacing mode prescription from 1989 to 2006. Experience of a single academic centre in Northern Greece

Hellenic Journal of Cardiology

Volumn 49, Issue 3, 2008, Pages 155-162

  Styliadis, Ioannis H ^a   Mantziari, Aggeliki P ^a,b   Gouzoumas, Nikolaos I ^a   Vassilikos, Vasilios P ^a   Paraskevaidis, Stelios A ^a   Mochlas, Sotirios T ^a   Boufidou, Amalia I ^a   Parcharidis, Georgios E ^a  

^a AHEPA UNIVERSITY HOSPITAL   (Greece)

^b NONE   (Greece)

Author keywords

Atrioventricular block; Heart failure; Observational retrospective; Sick sinus syndrome

Indexed keywords

AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; ASYSTOLE; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; CARDIAC PATIENT; CAROTID SINUS SYNDROME; CONTROLLED STUDY; FEMALE; GREECE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART PACING; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; RETROSPECTIVE STUDY; SICK SINUS SYNDROME; TACHYCARDIA;

AGED; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHY, HYPERTROPHIC; FEMALE; GREECE; HEART BLOCK; HEART FAILURE; HUMANS; MALE; PACEMAKER, ARTIFICIAL; SICK SINUS SYNDROME;

EID: 44849098682     PISSN: 10117970     EISSN: 10117970     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Nelson G. A brief history of cardiac pacing. Tex Heart Inst J. 1993; 20: 12-18.
2. Gold M. Permanent Pacing: new indications. Heart. 2001; 86: 335-360.
3. Fragakis N, Katsaris G. Arrhythmias in the elderly: Modern management. Hellenic J Cardiol. 2006; 47: 84-92.
4. Brignole M. An update on the treatment of vasovagal syncope. Hellenic J Cardiol. 2004; 45: 132-135.
5. Gregoratos G, Abrams J, Epstein AE, et al. ACC/AHA/-NASPE 2002 Guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: Summary article. Circulation. 2002; 106: 2145-2161.
6. Vardas PE, Ovsyscher EI. Geographic differences of pacemaker implant rates in Europe. J Cardiovasc Electrophysiol. 2002; 13(1 Suppl): S23-26.
7. Ector H, Rickards AF, Kappenberger L, et al; on behalf of the Working Group on Cardiac Pacing, a working group of the European Society of Cardiology. The registry of the European Working Group on Cardiac Pacing (EWGCP). Europace. 2000; 2: 251-255.
8. Cunningham D, Rickards T, Cunningham M. National Pacemaker Database. Annual report 2002 [Internet]. Available from: http://www.ccad.org.uk/.
9. Specialty Group for cardiac pacemakers, German National Agency for Performance and Measurement in Health Care. German Pacemaker Register, report 2003.
10. Vardas PE. Hellenic Cardiological Society, Working group on Cardiac Pacing and Electrophysiology. Greek pacing and ICD registry. Cardiac pacing in Greece 1992-2006.
11. Andersen HR, Nielsen JC, Thomsen PE, et al. Long-term follow up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet. 1997; 350: 1210-1216.
12. Lamas GA, Lee KL, Sweeney MO, et al. Ventricular pacing or dual-chamber pacing for sinus node dysfunction. Mode Selection Trial in Sinus Node Dysfunction (MOST). N Engl J Med. 2002; 346: 1854-1862.
13. Kerr CR, Connolly SJ, Abdollah H, et al. Canadian Trial of Physiologic Pacing. Effects of physiologic pacing during long-term follow up. Circulation. 2004; 109: 357-362.
14. Dretzke J, Toff WD, Lip GY, Raftery J, Fry-Smith A, Taylor R. Dual chamber ventricular pacemakers for sick sinus syndrome and atrioventricular block. Cochrane Database Syst Rev. 2004; 2: CD003710.
15. Zhang XH, Chen H, Siu CW, et al. New onset heart failure after permanent right ventricular pacing in patients with acquired high-grade atrioventricular block and normal left ventricular ejection fraction. J Cardiovasc Electrophysiol. 2008; 19: 136-141.
16. Chiladakis J, Koutsogiannis N, Kalogeropoulos A, Zagli F, Arvanitis P, Alexopoulos D. Unfavourable effects of continuous, atrial-synchronised ventricular pacing on ventricular systolic and diastolic function in patients with normal left ventricular ejection fraction: usefulness of tissue and colour Doppler echocardiography. Hellenic J Cardiol. 2007; 48: 335-340.
17. Nielsen JC, Kristensen L, Andersen HR, et al. AAIR versus DDDR in sick sinus syndrome. J Am Coll Cardiol. 2003; 42: 614-623.
18. Flammang D, Loteanu V, Hamani D, et al. Brady-tachy syndrome: Rapid atrial pacing efficacy in preventing atrial fibrillation recurrence assessed by reliable electrograms: the prefib pilot study. Europace. 2005; 7: 482-489.
19. Sweeney MO, Bank AJ, Nsah E., et al. Search AV Extension and Managed Ventricular Pacing for Promoting Atrioventricular Conduction (SAVE PACe) Trial. Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease. N Engl J Med. 2007; 357: 1000-1008.
20. Manolis A, Simeonidou E, Sousani E, Chiladakis J. Alternate sites for permanent cardiac pacing: A randomized study of novel technology. Hellenic J Cardiol. 2004; 45: 145-149.
21. Theodorakis G. Alternate pacing sites in the atria and the right ventricle. Hellenic J Cardiol. 2004; 45: 150-153.
22. Berney J. Indications and choices in pacemaker therapy. Tex Heart Inst J. 1991; 18: 170-178.
23. Fananapazir L, Epstein ND, Curiel RV, et al. Long term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation. 1994; 90: 2731-2742.
24. Kappenberger L, Linde C, Daubert C, et al. Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. PIC study Group. Eur Heart J. 1997; 18: 1249-1256.
25. Maron BJ, Nishimura RA, McKenna WJ, Rakowski H, Josephson ME, Kieval RS. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY). Circulation. 1999; 99: 2927-2933.
26. Kassotis J, Haq S, Mongwa M. Multiple cardiac arrhythmias detected by a dual chamber implantable cardioverter defibrillator in a patient with hypertrophic obstructive cardiomyopathy. Hellenic J Cardiol. 2004; 45: 57-60.
27. Georgakopoulos D, Tolis V. Hypertrophic cardiomyopathy in children and young adults. Hellenic J Cardiol. 2007; 48: 228-233.
28. Bryce M, Spielman S, Greenspan A, Kotler M. Evolving indications for permanent pacemakers. Ann Intern Med. 2001; 134: 1130-1141.
29. Hochleitner M, Hortnagl H, Ng CK, et al. Usefulness of physiologic dual-chamber pacing in drug-resistant idiopathic dilated cardiomyopathy. Am J Cardiol. 1990; 66: 198-202.
30. Hochleitner M, Hörtnagl H, Hörtnagl H, Fridrich L, Gschnitzer F. Long-term efficacy of physiologic dual-chamber pacing in the treatment of end-stage idiopathic dilated cardiomyopathy. Am J Cardiol. 1992; 70: 1320-1325.
31. Karagiannis S, Maounis T, Athanassopoulos G, et al. Cardiac resynchronisation therapy decreases the mitral coaptation point displacement in heart failure patients. Hellenic J Cardiol. 2006; 47: 198-205.
32. Kolokathis F, Theodorakis G, Livanis E, et al. Initial experience of biventricular pacing in patients with chronic severe heart failure. Hellenic J Cardiol. 2003; 44: 317-325.
33. Auricchio A, Stellbrink C, Sack S, et al. The Pacing Therapies for Congestive Heart Failure (PATH-CHF) study: rationale, design, and endpoints of a prospective randomised multicenter study. Am J Cardiol. 1999; 83: 130D-135D
34. Abraham WT, Fisher WG, Smith AL, et al. The MIRACLE Study: The InSync Clinical Trial Program. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002; 346: 1845-1918.
35. Chiladakis I, Agelopoulos G, Patsouras N, Paschalis A, Manolis A. A long term follow up of patients with a permanent pacemaker: Necessity of specific programmer. Hellenic J Cardiol. 2002; 43: 32-37.